Endothelin in cardiovascular disease: From atherosclerosis to heart failure

Journal of Cardiovascular Pharmacology

Volumn 35, Issue SUPPL. 2, 2000, Pages

  Best, P J M ^a   Lerman, A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atherosclerosis; Congestive heart failure; Coronary artery disease; Endothelin; Endothelin receptors

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CORONARY ARTERY DISEASE; EXTRACELLULAR MATRIX; HEART FAILURE; HEART HEMODYNAMICS; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; ENDOTHELINS; HEART FAILURE, CONGESTIVE; HUMANS; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION;

EID: 0033660338     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200000002-00014     Document Type: Review

References (10)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
3. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs
4. Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines
5. Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: Its possible correlation with bronchopulmonary dysplasia
6. Endothelin-1 evoked an increase and oscillations in cytosolic calcium concentration in adherent single human platelets and increased GMP-140 (P-selectin) in platelet suspension
7. Increased endothelin in experimental heart failure
8. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol
9. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure
10. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure